ANNEXURE A
I. | HUMAN PATHOGENS, ZOONOSES AND TOXINS, AS FOLLOWS: |
a. | Viruses, whether natural, synthetic, enhanced or modified, either in the form of isolated live cultures or as material, including living material which has been deliberately inoculated or contaminated with such cultures, as follows: |
▪ | Eastern equine encephalitis virus; |
▪ | Western equine encephalitis virus; |
▪ | Venezuelan equine encephalitis virus; |
▪ | Japanese encephalitis virus; |
▪ | Tick-borne encephalitis complex viruses, including Russian Spring-Summer encephalitis, Kyasanur Forest, Louping ill, Omsk haemorrhagic fever and Powassan; |
▪ | St Louis encephalitis virus; |
▪ | Murray Valley encephalitis virus; |
▪ | Rift Valley fever virus; |
▪ | Crimean-Congo haemorrhagic fever virus; |
▪ | Hantaviruses, including Hantaan, Seoul, Dobrava, Puumala and Sin Nombre; |
▪ | Arenaviruses, associated with haemorrhagic fevers including Lassa fever, Junin, Machupo, Lymphocytic choriomeningitis, Sabia, Flexal, Dandenong, Lujo and Guanarito; |
b. | Rickettsiae, whether natural, synthetic, enhanced or modified, either in the form of isolated live cultures or as material, including living material which has been deliberately inoculated or contaminated with such cultures, as follows: |
▪ | Bartonella quintana (Rochalimaea quintana, Rickettsia quintana); |
c. | Bacteria, whether natural, synthetic, enhanced or modified, either in the form of isolated live cultures or as material, including living material which has been deliberately inoculated or contaminated with such cultures, as follows: |
▪ | Clostridium perfringens, epsilon toxin producing types; |
▪ | Enterohaemorrhagic Escherichia coli, serotype 0157 and other verotoxin producing serotypes; |
▪ | Burkholderia mallei (Pseudomonas mallei); |
▪ | Burkholderia pseudomallei (Pseudomonas pseudomallei); |
▪ | Yersinia pseudotuberculosis. |
d. | Toxins, as follows, and subunits of toxins thereof: |
▪ | Clostridium perfringens toxins; |
▪ | Staphylococcus aureus toxins; |
▪ | Trichothecene mycotoxins, such as T-2 toxin, HT-2 toxin and Diacetoxyscirpenol toxin; |
▪ | Microcystin (Cyanginosin); |
▪ | Viscum album Lectin 1 (Viscumin); |
Except:
1. | Any goods in the form of a vaccine or toxoid. |
A vaccine is a medicinal or veterinary product in a pharmaceutical formulation licensed by, or having marketing or clinical trial authorisation from, the relevant South African regulatory authorities, which is intended to stimulate a protective immunological response in humans or animals in order to prevent disease in those to whom or to which it is administered.
2. | Botulinum toxins and Conotoxins meeting all of the following criteria: |
(a) | are pharmaceutical formulations designed for testing and human administration in the treatment of medical conditions; |
(b) | are pre-packaged for distribution as clinical or medical products; and |
(c) | are authorised by the relevant South African regulatory authority to be marketed as clinical or medical products |
II. | ANIMAL PATHOGENS, AS FOLLOWS: |
1. | Viruses, whether natural, synthetic, enhanced or modified, either in the form of isolated live cultures or as material, including living material which has been deliberately inoculated or contaminated with such cultures, as follows: |
▪ | African swine fever virus; |
▪ | African horse sickness virus; |
▪ | Avian influenza virus, which can be: |
2. | Defined as having high pathogenicity, as follows: |
i. | Type A viruses with an IVPI (intravenous pathogenicity index) in six-week-old chickens of greater than 1.2; or |
ii. | Type A viruses, H5 or H7 subtype, for which nucleotide sequencing has demonstrated multiple basic amino acids at the cleavage site of haemagglutinin; |
▪ | Foot-and-mouth disease virus; |
▪ | Porcine herpesvirus (Aujeszky's disease); |
▪ | Swine fever virus (Hog cholera virus); |
▪ | Newcastle disease virus; |
▪ | "Peste des petits ruminants" virus; |
▪ | Porcine enterovirus type 9 (swine vesicular disease virus); |
▪ | Vesicular stomatitis virus; |
2. | Mycoplasma mycoides subspecies mycoides SC (small colony), whether natural, synthetic, enhanced or modified, either in the form of isolated live cultures or as material, including living material which has been deliberately inoculated or contaminated with such Mycoplasma mycoides (mycoides SC). |
3. | Mycoplasma capricolum subspecies capripneumoniae ("strain F38") |
Except:
Any goods in the form of a vaccine or toxoid.
III. | PLANT PATHOGENS, AS FOLLOWS: |
a. | Bacteria, whether natural, synthetic, enhanced or modified, either in the form of isolated live cultures or as material which has been deliberately inoculated or contaminated with such cultures, as follows: |
▪ | Xanthomonas albilineans; |
▪ | Xanthomonas campestris pv. citri, including strains referred to as Xanthomonas campestris pv. citri types A, B, C, D, E or otherwise classified as Xanthomonas citri, Xanthomonas campestris pv. aurantifolia, Xanthomonas campestris pv. citrumelo, Xanthomonas axonopodis pv. citri, Xanthomonas axonopodis pv. citrumelo, Xanthomonas axonopodis pv. aurantifolii; |
▪ | Xanthomonas oryzae pv. oryzae; |
▪ | Clavibacter michiganensis subspecies sepedonicus (Corynebacterium michiganensis subspecies sepedonicum or Corynebacterium sepedonicum); |
▪ | Ralstonia solanacearum races 2 and 3 (Pseudomonas solanacearum races 2 and 3 or Burholderia solanacearum races 2 and 3). |
b. | Fungi, whether natural, synthetic, enhanced or modified, either in the form of isolated live cultures or as material which has been deliberately inoculated or contaminated with such cultures, as follows: |
▪ | Colletotrichum kahawae (Colletotrichum coffeanum var. virulans); |
▪ | Cochliobolus miyabeanus (Helminthosporium oryzae); |
▪ | Deuterophomonas tracheiphila (syn. Phoma tracheiphila); |
▪ | Microcyclus ulei (syn. Dothidella ulei); |
▪ | Monilia rorei (syn. Moniliophthora rorei); |
▪ | Puccinia graminis (syn. Puccinia graminis f. sp. tritici); |
▪ | Puccinia striiformis (syn. Puccinia glumarum); |
▪ | Magnaporthe grisea (Pyricularia grisea/Pyricularia oryzae). |
c. | Viruses, whether natural, synthetic, enhanced or modified, either in the form of isolated live cultures or as material, including living material which has been deliberately inoculated or contaminated with such cultures, as follows: |
▪ | Banana bunchy top virus; |
▪ | Potato Andean latent tymovirus; |
▪ | Potato spindle tuber viroid. |
IV. GENETICALLY MODIFIED MICRO-ORGANISMS AND GENETIC ELEMENTS, AS FOLLOWS:
a. | Genetically modified micro-organisms or genetic elements that contain nucleic acid sequences associated with pathogenicity, or may lead to pathogenicity of non-pathogenic sequences in organisms specified in (I.a) to (I.c) or (II) or (III). |
b. | Genetically modified micro-organisms or genetic elements that contain nucleic acid sequences coding for any of the toxins specified in (I.d) or subunits of toxins thereof. |